Signal: Illumina leads $15m investment in Broken String Biosciences
Embattled biotech giant Illumina has led series A funding into genomics mapping company Broken String Biosciences.
Deals
Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder
Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits
Signal: Pharma giant Novartis to spin-off generics brand
Signal: UK clinical research provider Ergomed bought out in $888m deal
Signal: Chinese economic slump hurts pharma firms invested in the region
Signal: Bruker continues acquisition spree with $108m PhenomeX purchase
Signal: Illumina under investigation by SEC over $8bn Grail acquisition
